Drug intelligence / Profile preview

Ci Mu

Development stage
Unknown
Lead developer
Red Coral Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Ci Mu (慈母) is an approved oral combination nutritional supplement developed by Guangdong Hongshanhu Pharmaceutical (also known as Red Coral Pharmaceutical Group). The formulation contains calcium gluconate, zinc gluconate, and lysine hydrochloride as its active ingredients. It is primarily indicated for the treatment and prevention of calcium and zinc deficiencies, particularly in pediatric populations. Clinical applications include addressing conditions such as osteoporosis, rickets, bone developmental disorders, growth retardation, and loss of appetite (anorexia). The product provides essential elemental minerals to support normal physiological functions and bone health, while lysine hydrochloride is included to promote growth and potentially enhance the absorption of minerals. It holds the Chinese drug approval number 国药准字H20059419 and is manufactured by Hubei Wushi Pharmaceutical under license.

Brand names
慈母Ci Mu
Other names
Calcium Gluconate and Zinc Oral Solution慈母®葡萄糖酸钙锌口服液Calcium gluconate & zinc oral solution

Beyond the preview

Go deeper on Ci Mu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ci Mu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call